论文部分内容阅读
在日益激烈的市场竞争中,浙江震元、华通医药、易心堂等三家企业借力资本市场,逐渐形成了胜于同行的竞争优势,成为绍兴药品流通行业的佼佼者或代表性企业。截至8月21日,A股上市公司共有3355家(包括多家已拿到证监会IPO批文但尚未正式公开发行的企业)。按省级行政区域来看,位列前三的分别是广东省(总共544家,深圳市一地便有264家,占比接近半数)、浙江省(391家)、江苏省(363家)。
In the increasingly fierce market competition, Zhejiang Zhenyuan, Huatong Medicine, Yi Xintang and other three companies leveraging on the capital market gradually formed a competitive advantage over their peers and became the leader or representative enterprise in the pharmaceutical distribution industry in Shaoxing. As of August 21, there were 3,355 A-share listed companies (including a number of companies that have obtained the SFC’s approval but have not yet been officially launched yet). According to the provincial administrative regions, the top three are Guangdong (544 in total, 264 in Shenzhen, accounting for nearly half), Zhejiang (391), Jiangsu (363) .